Pfizer stock: Twenty-one brokers set USD 28.72 consensus target for Pfizer stock

Published on 10/16/2026 at 17:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached USD 15.03 billion in the second quarter. Pfizer stock costs EUR 26.31 on October 16, 2026, down 1.05 percent versus the Xetra close.

Broker targets and operating figures

Twenty-one brokerages set an average Pfizer target of USD 28.72 on October 15, 2026.
Second-quarter revenue reached USD 15.03 billion against USD 14.40 billion consensus.
Pfizer stock costs EUR 26.31 at 5:34 p.m. CEST at Lang & Schwarz on October 16, 2026, 1.05 percent below the Xetra close of October 15, 2026.
Pfizer traded at a price-to-earnings ratio of 38.44 on October 15, 2026.

Isometrisches 3D-Diagramm einer Pharma-Wertschöpfungskette, Symbolbild für Pfizer Inc — Isometrische 3D-Grafik der Pharma-Wertschöpfungskette zeigt Produktionsprozesse ähnlich Pfizer Inc., ISIN US7170811035, im Überblick, Illustration mit AI erstellt.

Twenty-one brokerages assigned Pfizer an average 12-month target of USD 28.72 on October 15, 2026, leaving the target 1.71 percent below the reported USD 29.22 share price, according to MarketBeat. Pfizer stock was trading at EUR 26.31 at Lang & Schwarz on October 16, 2026 at 5:34 p.m. CEST, down 1.05 percent versus the Xetra close of October 15, 2026 at EUR 26.59.

Revenue clears consensus

Pfizer reported USD 15.03 billion in revenue for the second quarter of 2026, compared with a USD 14.40 billion consensus estimate. The company also posted adjusted diluted earnings per share of USD 0.77 against consensus of USD 0.68, according to MarketBeat. The reported quarter included a USD 0.04 loss per share, so adjusted and reported figures point in different directions.

Trading range stays wide

The Xetra quote showed a daily high of EUR 26.37, a low of EUR 26.11 and volume of 17,502 shares on October 16, 2026. The separate Nasdaq reference was USD 29.22 on October 15, 2026, with a 52-week range of USD 23.62 to USD 29.49, according to MarketBeat. That range puts the US share near its upper boundary, while the euro quote remains below the latest consensus target when the currencies are kept separate.

Valuation and next date

Pfizer carried a USD 166.5 billion market capitalization and a price-to-earnings ratio of 38.44 on October 15, 2026. The quarterly dividend was USD 0.43 per share, equivalent to a 5.90 percent yield, with the ex-dividend date listed as November 6, 2026, according to MarketBeat. Pfizer lists a conference call for November 3, 2026, on its corporate website.

Comparison with peers

Pfizer Inc.: minus 1.05 percent, P/E 38.44, market capitalization USD 166.5 billion.

Johnson & Johnson (NYSE, USD): plus 1.57 percent, P/E 38.84, market capitalization USD 619.9 billion.

Bristol-Myers Squibb Company (NYSE, USD): plus 0.31 percent, P/E 13.38, market capitalization USD 124.1 billion.

Pfizer price at Lang & Schwarz

The euro quote stood at EUR 26.31 at Lang & Schwarz on October 16, 2026 at 5:34 p.m. CEST, 1.05 percent below the Xetra close of October 15, 2026 at EUR 26.59. The Nasdaq share had last traded at USD 29.22 on October 15, 2026.

The further course of trading is shown by the continuously updated real-time quote of Pfizer stock.